What is the workup for a patient with Mobitz Type 2 (second-degree atrioventricular) AV (atrioventricular) block?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 30, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Workup for Mobitz Type II AV Block

All patients with Mobitz Type II second-degree AV block require immediate cardiac monitoring, urgent cardiology consultation, and preparation for permanent pacemaker implantation, as this is a Class I indication regardless of symptoms due to unpredictable progression to complete heart block. 1

Immediate Actions

  • Place transcutaneous pacing pads immediately upon recognition, as Mobitz Type II carries high risk of sudden progression to complete heart block 1
  • Initiate continuous cardiac monitoring until permanent pacemaker is placed 1
  • Assess hemodynamic stability including blood pressure, signs of low cardiac output, and symptoms of syncope or presyncope 1

Diagnostic Workup

Essential Studies

  • 12-lead ECG to confirm the diagnosis—look for constant PR intervals before and after blocked P waves (distinguishing it from Mobitz Type I which shows progressive PR prolongation) and evaluate QRS width, as wide QRS suggests more extensive His-Purkinje disease 1, 2
  • Transthoracic echocardiography (Class I recommendation) to assess for underlying structural heart disease, cardiomyopathy, or valvular abnormalities 1
  • Exercise stress testing to evaluate for exercise-induced worsening of AV block and assess chronotropic response 3, 1
  • Ambulatory ECG monitoring (Holter or event monitor) to document progression to higher-grade block and assess burden of conduction abnormalities 3

Laboratory Evaluation

  • Electrolyte panel including potassium, calcium, and magnesium to rule out reversible metabolic causes 1
  • Consider thyroid function tests as both hypothyroidism and hyperthyroidism can cause Mobitz Type II 4
  • Cardiac biomarkers (troponin) if acute myocardial infarction is suspected, as ischemic heart disease is a primary cause 4

Advanced Imaging (Based on Initial Results)

  • Cardiac MRI may be considered if echocardiogram and laboratory results suggest infiltrative cardiomyopathy (sarcoidosis, amyloidosis), myocarditis, or to assess for myocardial scar 3, 4

Critical Diagnostic Pitfalls to Avoid

  • Do not confuse with Mobitz Type I (Wenckebach): Mobitz Type II has constant PR intervals, occurs in the His-Purkinje system with unreliable escape rhythms, and requires pacemaker; Mobitz Type I shows progressive PR prolongation, occurs at the AV node, and is generally benign 1, 5
  • Beware of pseudo-AV block: Concealed His bundle or junctional extrasystoles can mimic Mobitz Type II—look for premature QRS complexes that may be hidden 2, 6
  • 2:1 AV block cannot be classified as Mobitz I or II on surface ECG alone; electrophysiologic study or stress testing may be needed to determine the level of block 2
  • Vagal surge mimicry: Simultaneous sinus slowing with AV block may resemble Mobitz Type II but is typically benign vagal phenomenon—true Mobitz Type II requires stable sinus rate 2, 7

Acute Management While Awaiting Pacemaker

For Hemodynamically Unstable Patients

  • Atropine 0.5 mg IV every 3-5 minutes up to maximum 3 mg total dose may be attempted, though often ineffective since block occurs below the AV node in the His-Purkinje system 1, 8
  • Urgent transvenous temporary pacing for patients not responding to atropine or with hemodynamic compromise, with transcutaneous pacing as bridge 1
  • Access via femoral, internal jugular, or subclavian veins to right ventricular apex 1

Atropine Caveats

  • Doses <0.5 mg may paradoxically worsen AV block via central vagal stimulation 9, 8
  • Atropine is unreliable for Mobitz Type II as the block is infranodal 1, 8

Definitive Management

  • Permanent pacemaker implantation is mandatory for all patients with Mobitz Type II, even if asymptomatic, due to unpredictable progression to complete heart block with risk of Adams-Stokes attacks and sudden death (Class I indication) 1, 10
  • Dual-chamber pacemakers should be programmed to maintain native AV conduction when possible to prevent pacing-induced ventricular dysfunction 1

Special Clinical Scenarios

  • Post-cardiac surgery or TAVR: If Mobitz Type II persists beyond 7-10 days postoperatively, permanent pacemaker is indicated; most postoperative AV block recovers within this timeframe 1, 4
  • Neuromuscular diseases (myotonic dystrophy, Kearns-Sayre syndrome): Consider pacemaker with defibrillator capability if meaningful survival >1 year expected 1, 4
  • Infiltrative cardiomyopathies (cardiac sarcoidosis, amyloidosis): Consider pacemaker with defibrillator capability 1, 4
  • Acute MI setting: Represents Class Ia indication for temporary transvenous pacing, followed by permanent pacemaker if block persists 1

Referral

  • Immediate electrophysiologist referral is essential for all confirmed cases of Mobitz Type II 3

References

Guideline

Management of Mobitz Type II Second-Degree Atrioventricular Block

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Causes and Characteristics of Mobitz Type II Atrioventricular Block

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Second-degree atrioventricular block: Mobitz type II.

The Journal of emergency medicine, 1993

Research

[Concealed but not invisible].

Giornale italiano di cardiologia (2006), 2011

Guideline

Management of Second Degree Heart Block Type 1 (Wenckebach)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.